1. Home
  2. MIST vs INGN Comparison

MIST vs INGN Comparison

Compare MIST & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$1.16

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.23

Market Cap

177.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIST
INGN
Founded
2003
2001
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.3M
177.1M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
MIST
INGN
Price
$1.16
$6.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$8.00
$11.25
AVG Volume (30 Days)
1.1M
195.1K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.42
EPS
N/A
N/A
Revenue
N/A
$348,668,000.00
Revenue This Year
$2,915.14
$8.03
Revenue Next Year
N/A
$7.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.86
52 Week Low
$1.00
$5.34
52 Week High
$3.06
$9.13

Technical Indicators

Market Signals
Indicator
MIST
INGN
Relative Strength Index (RSI) 36.21 41.59
Support Level $1.00 $6.00
Resistance Level $1.42 $6.73
Average True Range (ATR) 0.06 0.24
MACD -0.00 -0.03
Stochastic Oscillator 5.71 14.93

Price Performance

Historical Comparison
MIST
INGN

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

Share on Social Networks: